Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of the Viz ...
Includes real-world clinical data from Biodesix researchers and independent Healthcare ProfessionalsLOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading ...
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, making early and accurate diagnosis essential for improving patient outcomes.
Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit sales for its CyPath® Lung ...
Please provide your email address to receive an email when new articles are posted on . Pulmonary nodule stability was frequently observed on veterans’ follow-up CT scans. Other findings on follow-up ...
Please provide your email address to receive an email when new articles are posted on . Researchers did not find noninferiority when comparing less with more intensive module surveillance. They also ...
South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration's 510(k) clearance for its latest AI-powered analysis software for screening lung nodules. The ...
Patients were satisfied with receiving their lung cancer screening (LCS) pulmonary nodule results via letter and considered the amount of information provided in the letter appropriate. Study Design: ...
If you meet the criteria for lung cancer screening — meaning you are or have a history of being a heavy smoker, and are between 50 and 80 years old — experts recommend an annual low-dose computerized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results